Redmile Group as of March 31, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 70 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 15.7 | $502M | 13M | 38.77 | |
Amicus Therapeutics (FOLD) | 6.6 | $212M | 22M | 9.47 | |
Argenx Se Sponsored Adr (ARGX) | 5.1 | $163M | 516k | 315.31 | |
Livanova SHS (LIVN) | 5.0 | $161M | 2.0M | 81.83 | |
Krystal Biotech (KRYS) | 3.8 | $121M | 1.8M | 66.54 | |
Kymera Therapeutics (KYMR) | 3.5 | $111M | 2.6M | 42.32 | |
Adc Therapeutics Sa SHS (ADCT) | 3.4 | $109M | 7.4M | 14.69 | |
Science 37 Holdings | 3.3 | $106M | 20M | 5.35 | |
Beam Therapeutics (BEAM) | 3.3 | $105M | 1.8M | 57.30 | |
The Beauty Health Company Com Cl A (SKIN) | 2.8 | $90M | 5.3M | 16.88 | |
Igm Biosciences (IGMS) | 2.8 | $89M | 3.3M | 26.73 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $70M | 2.0M | 34.06 | |
Absci Corp (ABSI) | 2.1 | $68M | 8.0M | 8.43 | |
Regenxbio Inc equity us cm (RGNX) | 2.0 | $66M | 2.0M | 33.19 | |
Seagen | 2.0 | $64M | 441k | 144.05 | |
Replimune Group (REPL) | 2.0 | $63M | 3.7M | 16.98 | |
Atara Biotherapeutics | 1.8 | $58M | 6.2M | 9.29 | |
Centene Corporation (CNC) | 1.7 | $55M | 649k | 84.19 | |
ImmunoGen | 1.4 | $44M | 9.2M | 4.76 | |
Stoke Therapeutics (STOK) | 1.3 | $43M | 2.0M | 21.05 | |
Nurix Therapeutics (NRIX) | 1.3 | $42M | 3.0M | 14.01 | |
Augmedix (AUGX) | 1.3 | $42M | 14M | 2.94 | |
Verve Therapeutics (VERV) | 1.3 | $42M | 1.8M | 22.82 | |
Anthem (ELV) | 1.3 | $41M | 83k | 491.22 | |
Repare Therapeutics Ord (RPTX) | 1.2 | $39M | 2.7M | 14.24 | |
1life Healthcare | 1.2 | $38M | 3.4M | 11.08 | |
Oak Street Health | 1.0 | $32M | 1.2M | 26.88 | |
Tandem Diabetes Care Com New (TNDM) | 1.0 | $32M | 271k | 116.29 | |
Somalogic Class A Com | 1.0 | $31M | 3.9M | 8.02 | |
Scholar Rock Hldg Corp (SRRK) | 1.0 | $31M | 2.4M | 12.89 | |
Invitae (NVTAQ) | 0.9 | $30M | 3.8M | 7.97 | |
Nevro (NVRO) | 0.9 | $30M | 411k | 72.33 | |
Gritstone Oncology Ord (GRTS) | 0.9 | $28M | 6.9M | 4.12 | |
UnitedHealth (UNH) | 0.9 | $27M | 53k | 509.96 | |
Prothena Corp SHS (PRTA) | 0.8 | $27M | 736k | 36.57 | |
Iveric Bio | 0.8 | $25M | 1.5M | 16.83 | |
Shattuck Labs (STTK) | 0.7 | $24M | 5.6M | 4.26 | |
Stevanato Group S P A Ord Shs (STVN) | 0.7 | $23M | 1.2M | 20.12 | |
Akero Therapeutics (AKRO) | 0.7 | $23M | 1.6M | 14.19 | |
Pliant Therapeutics (PLRX) | 0.7 | $22M | 3.1M | 7.01 | |
ICU Medical, Incorporated (ICUI) | 0.7 | $22M | 97k | 222.64 | |
Entrada Therapeutics (TRDA) | 0.6 | $18M | 2.0M | 9.39 | |
Bioventus Com Cl A (BVS) | 0.6 | $18M | 1.3M | 14.10 | |
Nuvation Bio Com Cl A (NUVB) | 0.6 | $18M | 3.5M | 5.26 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $18M | 115k | 155.67 | |
Oncology Institu (TOI) | 0.5 | $17M | 2.4M | 7.13 | |
Rapt Therapeutics (RAPT) | 0.5 | $17M | 749k | 21.99 | |
Allakos (ALLK) | 0.5 | $15M | 2.6M | 5.70 | |
Zymeworks | 0.4 | $14M | 2.1M | 6.55 | |
Alx Oncology Hldgs (ALXO) | 0.4 | $13M | 772k | 16.90 | |
Lava Therapeutics Nv SHS (LVTX) | 0.4 | $12M | 2.8M | 4.40 | |
Medavail Holdings Ord | 0.3 | $11M | 11M | 0.97 | |
Hookipa Pharma Inc equity | 0.3 | $11M | 4.6M | 2.28 | |
Adagio Therapeutics (IVVD) | 0.3 | $8.8M | 1.9M | 4.56 | |
Annexon (ANNX) | 0.3 | $8.7M | 3.2M | 2.73 | |
Alpha Teknova (TKNO) | 0.2 | $7.8M | 568k | 13.81 | |
Neoleukin Therapeutics | 0.2 | $6.5M | 3.5M | 1.88 | |
Deciphera Pharmaceuticals | 0.2 | $6.2M | 665k | 9.27 | |
Immatics SHS (IMTX) | 0.2 | $5.8M | 725k | 7.99 | |
Allovir (ALVR) | 0.2 | $5.6M | 823k | 6.75 | |
Stereotaxis Com New (STXS) | 0.2 | $5.5M | 1.5M | 3.73 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $4.7M | 1.6M | 2.94 | |
Tcr2 Therapeutics Inc cs | 0.1 | $3.0M | 1.1M | 2.76 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $2.7M | 1.0M | 2.56 | |
Atreca Cl A Com (BCEL) | 0.1 | $2.5M | 800k | 3.17 | |
Sonendo (SONX) | 0.1 | $2.0M | 498k | 4.01 | |
Ayala Pharmaceuticals Incorporated | 0.1 | $1.8M | 450k | 3.98 | |
Cabaletta Bio (CABA) | 0.0 | $1.4M | 696k | 2.03 | |
Cytosorbents Corp Com New (CTSO) | 0.0 | $850k | 266k | 3.19 | |
Epizyme | 0.0 | $523k | 455k | 1.15 |